This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Rodriguez R, Jover V, Orozco I, Domenech J.DRESS syndrome in a 19-year-old patient following the administration of first-line antituberculosis drugs. Journal of Investigational Allergology and Clinical Immunology 22: 380-381, No. 5, 2012 - Spain
Additional information
Key words
adverse reactions; DRESS-syndrome; Rifampicin; Isoniazid; drug-induced; Pyrazinamide; Ethambutol
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Antituberculars. React. Wkly. 1427, 11 (2012). https://doi.org/10.2165/00128415-201214270-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214270-00030